GlassScriptPhysician profile
Henry B Carroll
NPI 1336140334
$3,443.78
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,378 · 2020: $1,385 · 2021: $681.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $588.00 | 2019-2021 | |
| Astellas Pharma US INC | $436.16 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $291.06 | 2019-2021 | |
| Abbvie INC. | $200.91 | 2019-2021 | |
| Amarin Pharma, INC. | $192.00 | 2019-2021 | |
| Allergan, INC. | $169.12 | 2019-2020 | |
| Amgen INC. | $167.64 | 2019-2021 | |
| Lilly USA, LLC | $158.22 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $154.53 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $149.06 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $144.65 | 2019-2021 | |
| Pfizer INC. | $138.62 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $121.90 | 2019-2021 | |
| Eisai INC. | $74.08 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $55.48 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $53.22 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $49.96 | 2019-2020 | |
| Biohaven Pharmaceuticals, INC. | $36.20 | 2021 | |
| Adlon Therapeutics L.P. | $33.10 | 2020 | |
| Nestle Healthcare Nutrition INC. | $32.28 | 2020-2021 | |
| Glaxosmithkline, LLC. | $28.31 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $26.23 | 2019-2020 | |
| Vivus LLC | $21.07 | 2019 | |
| Therapeuticsmd, INC. | $20.42 | 2019 | |
| Mylan Specialty L.P. | $19.75 | 2020 | |
| Daiichi Sankyo INC. | $17.53 | 2020 | |
| Nalpropion Pharmaceuticals LLC | $13.86 | 2019 | |
| Genentech USA, INC. | $13.81 | 2019 | |
| Dexcom, INC. | $12.38 | 2021 | |
| Horizon Therapeutics Plc | $12.24 | 2020 | |
| Aytu Biopharma, INC. | $11.99 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Carroll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.